Skip to content

Clinical trial of cervical fluid-based cytology image-assisted diagnostic software

Clinical trial of cervical fluid-based cytology image-assisted diagnostic software

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078722
Enrollment
Unknown
Registered
2023-12-15
Start date
2023-04-07
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Gold Standard:The results of the cytology expert group were selected as the gold standard. The participating center will designate one clinical cytology expert (definition of expert: associate chief p
Index test:Cervical fluid-based cytology image-assisted diagnostic software

Sponsors

Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-75 (including 18-75); 2) Subjects requiring liquid-based cytology; 3) The subject will voluntarily participate and sign the informed consent after the informed consent; Cervical liquid based cytology slides: 1) The background is clean and the cells are evenly spread; 2) Good cell fixation and intact cell morphology; 3) The total number of squamous cells in the entire slice is greater than 5000; 4) The chromatin in the nucleus is clear and granular; 5) No large amount of blood, mucus, or inflammatory cells covering; 6) No artificial illusion, no drying phenomenon; 7) No dry sealing phenomenon; No environmental reagent impact; 8) No overflow of sealing adhesive, no damage, and no marking with a marker pen. Cervical fluid based cytology images: 1) Specify the image scanned by the digital scanner; 2) Cervical fluid based cytology images with good reliability.

Exclusion criteria

Exclusion criteria: 1) Persons who do not have full capacity for civil conduct; 2) Patients with a history of hysterectomy and cervical conectomy; 3) Subjects of childbearing age who test positive for pregnancy; 4) Lactating subjects; 5) menstruating subjects; 6) Subjects with a history of pelvic radiotherapy; 7) Subjects with a history of chemotherapy; 8) Subjects with asexual life history; 9) Subjects with critical and severe diseases; 10) Participants who have participated in clinical trials or are participating in other clinical trials within the past three months; 11) Participants considered unsuitable for this clinical trial.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;

Secondary

MeasureTime frame
Independent diagnostic accuracy of software;Film reading efficiency;Positive predictive value, negative predictive value;

Countries

China

Contacts

Public ContactZHU Lan

Chinese Academy of Medical Sciences & Peking Union Medical College Hospital

zhu_julie@vip.sina.com+86 10 6915 1320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026